Regeneron Pharmaceuticals (REGN)
(Delayed Data from NSDQ)
$1,024.09 USD
-20.57 (-1.97%)
Updated Jul 3, 2024 01:00 PM ET
After-Market: $1,023.90 -0.19 (-0.02%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: BMO |
6/2024 | $10.57 | -3.13% |
Earnings Summary
For their last quarter, Regeneron Pharmaceuticals (REGN) reported earnings of $9.55 per share, missing the Zacks Consensus Estimate of $10.20 per share. This reflects a negative earnings surprise of 6.37%. Look out for REGN's next earnings release on August 01, 2024. For the next earning release, we expect the company to report earnings of $10.57 per share, reflecting a year-over-year increase of 3.22%.
Earnings History
Price & Consensus
Zacks News for REGN
Regeneron (REGN) Gets Positive CHMP Opinion for Lymphoma Drug
REGN: What are Zacks experts saying now?
Zacks Private Portfolio Services